Support Alert

Drug Safety update: Oral tacrolimus products: reminder to prescribe and dispense by brand name only

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for oral tacrolimus products. Inadvertent switching between tacrolimus products has been associated with reports of toxicity and graft rejection.

Further details of the safety update, advice and recommendations are available on the MHRA website.